| Vol. 14.36 – 15 September, 2022 |
| |
|
|
| Scientists investigated repair mechanisms of the amnion, a layer of epithelial cells in the amniotic sac closest to the embryo. [Science Signaling] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators transdifferentiated human umbilical cord MSCs into induced retinal pigment epithelial cells using a cocktail of five transcription factors. [Cell Death & Disease] |
|
|
|
| Human umbilical cord-derived MSC treatment improved 2,4,6-trinitrobenzenesulfonic acid-induced colitis by increasing survival rates and relieving symptoms. [Stem Cell Research & Therapy] |
|
|
|
| Researchers designed a study to determine the mechanism of cadmium exposure during pregnancy impaired placental angiogenesis that was associated with the occurrence of preeclampsia. [Ecotoxicology and Environmental Safety] |
|
|
|
| Trophoblasts cells and human umbilical vein endothelial cells were cultured on the opposite sides of an extracellular matrix gel in a compartmental microfluidic system, forming a physiological barrier between the co-flow tubular structure to mimic a simplified maternal–fetal interface in placental villi. [Scientific Reports] |
|
|
|
| Researchers examined the efficacy of autophagy in placental MSCs of fetal origin in either IL-1β treatment or bleomycin induced pulmonary fibrosis mice model. [Molecular Immunology] |
|
|
|
|
| The authors review the immunomodulatory features of MSC besides the current understanding of different sources of MSC in the angiogenic treatment of critical limb ischemia subjects and their potential applications as therapeutic agents. [Stem Cell Research & Therapy] |
|
|
|
|
| IMAC Holdings, Inc. announced it has completed the third cohort of its Phase I clinical trial for its investigational compound utilizing umbilical cord-derived allogenic MSCs for the treatment of bradykinesia due to Parkinson’s disease. [IMAC Holdings, Inc. (GlobeNewswire, Inc.)] |
|
|
|
|
| Novemeber 17 – 18, 2022 Lisbon, Portugal |
|
|
|
|
|
| University of California Santa Cruz – Santa Cruz, California, United States |
|
|
|
| Karolinska Institutet – Flemingsberg, Sweden |
|
|
|
| Harvard Stem Cell Institute – Boston, Massachusetts, United States |
|
|
|
| STEMCELL Technologies, Inc. – Vancouver, British Columbia, Canada |
|
|
|
| University of Copenhagen – Copenhagen, Denmark |
|
|
|
|